Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,473–2,480 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
LianBio Mavacamten Precision Diastolic Disease (HFpEF) Phase 2 oral Cardiology
LianBio NX-13 - (NEXUS) Ulcerative Colitis (UC) Phase 2 Ongoing Oral Gastroenterology
LianBio Omilancor (BT-11) Crohn’s Disease Phase 2 Trial Discontinued Oral Gastroenterology
LianBio Omilancor (BT-11) Ulcerative Colitis Phase 2 Trial Discontinued Oral Gastroenterology
Ligand Pharmaceuticals Incorporated Lasofoxifene + abemaciclib - (ELAINE-3) ER+/HER2- breast cancer with an ESR1 mutation Phase 3 Enrollment Initiation Oral Oncology
Ligand Pharmaceuticals Incorporated Lasofoxifene - (ELAINE 1) ER+/HER2- breast cancer Phase 3 Oral Oncology
Ligand Pharmaceuticals Incorporated CS1001 Gastric adenocarcinoma or gastro-esophageal junction adenocarcinoma. Phase 3 Intravenous Oncology
Ligand Pharmaceuticals Incorporated V116 - (STRIDE-10) Pneumococcal vaccine Phase 3 Data Released Intramuscular Immunology